Image credit: Jialun Zhu, Shuyu Lin, and Yichao Zhao (I²BL/UCLA)
Engineers at the UCLA Samueli School of Engineering and their colleagues at Stanford School of Medicine have demonstrated that drug levels inside the body can be tracked in real time using a custom smartwatch that analyzes the chemicals found in sweat. This wearable technology could be incorporated into a more personalized approach to medicine — where an ideal drug and dosages can be tailored to an individual.
A study detailing the research was published in Proceedings of the National Academy of Sciences.
In general, medications are prescribed with a ‘one-size-fits-all’ approach — drugs are designed and prescribed based on statistical averages of their effectiveness. There are guidelines for factors such as patients’ weight and age. But in addition to these basic differentiators, our body chemistry constantly changes — depending on what we eat and how much we’ve exercised. And on top of these dynamic factors, every individual’s genetic makeup is unique and hence responses to medications can vary. This affects how fast drugs are absorbed, take effect and get eliminated from an individual.
According to the researchers, current efforts to personalize the drug dosage rely heavily on repeated blood draws at the hospital. The samples are then sent out to be analyzed in central labs. These solutions are inconvenient, time-consuming, invasive and expensive. That is why they are only performed on a small subset of patients and on rare occasions.
“We wanted to create a wearable technology that can track the profile of medication inside the body continuously and non-invasively,” said study leader Sam Emaminejad, an assistant professor of electrical and computer engineering at UCLA. “This way, we can tailor the optimal dosage and timing of the intake for each individual. And using this personalization approach, we can improve the efficacy of the therapeutic treatments.”
Because of their small molecular sizes, many different kinds of drugs end up in sweat, where their concentrations closely reflect the drugs’ circulating levels. That’s why the researchers created a smartwatch, equipped with a sensor that analyzes the sampled tiny droplets of sweat.
The team’s experiment tracked the effect of acetaminophen, a common over-the-counter pain medication, on individuals over the period of a few hours. First, the researchers stimulated sweat glands on the wrist by applying a small electric current, the same technique that Emaminejad’s research group demonstrated in previous wearable technologies.
This allowed the researchers to detect changes in body chemistry, without needing subjects to work up a sweat by exercising. As different drugs each have their own unique electrochemical signature, the sensor can be designed to look for the level of a particular medication at any given time.
“This technology is a game-changer and a significant step forward for realizing personalized medicine,” said study co-author Ronald W. Davis, a professor of biochemistry and genetics at Stanford Medical School. “Emerging pharmacogenomic solutions, which allow us to select drugs based on the genetic makeup of individuals, have already shown to be useful in improving the efficacy of treatments. So, in combination with our wearable solution, which helps us to optimize the drug dosages for each individual, we can now truly personalize our approaches to pharmacotherapy.”
What makes this study significant is the ability to accurately detect a drug’s unique electrochemical signal, against the backdrop of signals from many other molecules that may be circulating in the body and in higher concentrations than the drug, said the study’s lead author Shuyu Lin, a UCLA doctoral student and member of Emaminejad’s Interconnected and Integrated Bioelectronics Lab (I²BL). Emaminejad added that the technology could be adapted to monitor medication adherence and drug abuse.
“This could be particularly important for individuals with mental health issues, where doctors prescribe them prolonged pharmacotherapy treatments,” he said. ” The patients could benefit from such easy-to-use, noninvasive monitoring tools, while doctors could see how the medication is doing in the patient.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tracking medication levels
- IQVIA Institute for Human Data Science Study: Biosimilars Reach Inflection Point – On Track to Reduce Drug Costs by $100 Bn Over Next Five Yearson October 6, 2020 at 10:49 am
Biosimilar medicine availability and use are growing and on track to reduce drug costs by $100 billion over the next five years, according to ...
- Trump said solving the opioid crisis was a top priority. His drug office’s track record suggests otherwise.on October 3, 2020 at 1:10 pm
President Donald Trump on Thursday expressed his deep support for Americans facing drug addiction in a proclamation of National Substance Abuse Prevention Month.
- BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307on October 2, 2020 at 5:31 am
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a pioneer in developing treatments for phenylketonuria (PKU) and gene therapies, announced today that the U.S. Food and Drug Administration (FDA) has ...
- Implementation date for track and trace system for exports of drug formulations extendedon September 22, 2020 at 7:52 am
The date for implementation of track and trace system for export of drug formulations with respect to maintain the parent-child relationship in packaging levels and its uploading on central portal ...
- Govt extends implementation date for track and trace for ...Govt extends implementation date for track and trace for ...on September 21, 2020 at 5:00 pm
As per the track and trace system, manufacturers or exporters of drug formulations will have to print the barcode as per the global standards at different packaging levels — primary, secondary ...
Go deeper with Google Headlines on:
Tracking medication levels
Go deeper with Bing News on:
Personalized drug dosage
- Voluntis Announces Issuance of US Patent for the Proprietary Algorithm Engine of Its Theraxium Digital Therapeutic Platformon October 6, 2020 at 9:30 am
Regulatory News: Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960) (Paris:VTX), a leader in digital therapeutics, announces today the issuan ...
- Outlook on the 3D Printed Drugs Global Market to 2027 - by Dosage Forms, Technology and Geography - ResearchAndMarkets.comon October 5, 2020 at 3:36 am
Impact and Global Analysis by Dosage Forms; Technology, and Geography" report has been added to ResearchAndMarkets.com's offering.
- UnitedHealth Dives Into Digital Pharmacy With DivvyDose Buyouton October 1, 2020 at 12:01 pm
UnitedHealth Group Inc. UNH has acquired Illinois-based DivvyDose, an online pharmacy startup. Founded in 2015, DivvyDose is a full-service pharmacy. It delivers patients’ pills in pre-sorted packs at ...
- 5 Ways to Ensure Medication Safety During COVID-19on October 1, 2020 at 11:16 am
PRNewswire/ -- (Family Features) During the COVID-19 pandemic, staying healthy is top of mind. For individuals at risk for or diagnosed with COVID-19, ...
- Roche shells out $200M for rights to Vaccibody's neoantigen cancer vaccineon October 1, 2020 at 8:35 am
Roche's Genentech arm is putting down $200 million in upfronts and near-term payments — and potentially $515M more down the road — for global rights to Norwegian biotech Vaccibody's neoantigen cancer ...